The Clorox Company $CLX Shares Sold by Northeast Investment Management

Key Points

• Northeast Investment Management has reduced its stake in The Clorox Company by 16.4%, now owning 43,086 shares valued at approximately $5.17 million after selling 8,461 shares.
• Analyst ratings are predominantly cautious, with Deutsche Bank and Bank of America lowering their price targets while maintaining a "hold" or "neutral" rating.
• Clorox recently announced a quarterly dividend of $1.24 per share, representing an annualized yield of 4.1%, with the dividend payment scheduled for November 6th.

Northeast Investment Management lowered its stake in The Clorox Company (NYSE:CLX - Free Report) by 16.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,086 shares of the company's stock after selling 8,461 shares during the quarter. Northeast Investment Management's holdings in Clorox were worth $5,173,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. American National Bank & Trust lifted its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company's stock worth $26,000 after purchasing an additional 89 shares during the period. Ransom Advisory Ltd acquired a new stake in Clorox in the 1st quarter valued at about $35,000. GW&K Investment Management LLC lifted its holdings in Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after acquiring an additional 208 shares during the last quarter. Roble Belko & Company Inc lifted its holdings in Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the last quarter. Finally, IMA Advisory Services Inc. acquired a new stake in Clorox in the 1st quarter valued at about $58,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on CLX shares. Deutsche Bank Aktiengesellschaft cut their price target on shares of Clorox from $135.00 to $128.00 and set a "hold" rating for the company in a report on Monday, October 13th. Bank of America cut their price target on shares of Clorox from $135.00 to $125.00 and set a "neutral" rating for the company in a report on Wednesday, October 8th. Wells Fargo & Company cut their price target on shares of Clorox from $130.00 to $125.00 and set an "equal weight" rating for the company in a report on Thursday, September 25th. The Goldman Sachs Group cut their price target on shares of Clorox from $115.00 to $110.00 and set a "sell" rating for the company in a report on Wednesday, October 1st. Finally, BNP Paribas Exane cut their price target on shares of Clorox from $118.00 to $110.00 and set an "underperform" rating for the company in a report on Friday. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, Clorox has an average rating of "Reduce" and an average price target of $130.20.

Insider Transactions at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.63% of the company's stock.

Clorox Price Performance

NYSE CLX opened at $119.73 on Friday. The stock's 50-day moving average price is $121.61 and its two-hundred day moving average price is $127.73. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The company has a market cap of $14.58 billion, a PE ratio of 18.36, a PEG ratio of 0.99 and a beta of 0.52. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox's payout ratio is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.